Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …
With widespread alarm about deaths linked to alcohol-and-caffeine-laced commercial drinks, it’s easy to overlook problems that may be linked to the so-called energy drinks that spawned them. But a number of scientists are worried about highly caffeinated beverages like Red Bull, Rockstar, Monster and Full Throttle, which are popular among …
DRUG maker Venus Remedies on Wednesday said it has received UK health regulator's approval to market 'Gemcitabine', used in treating cancer, in the UK market. The Chandigarh-based firm has got the approval from Medicine and Healthcare Regulatory Agency (MHRA), UK for Gemcitabine in two strengths of 200 mg and 1,000 …
A recent shift in the drug product environment for Africa has seen a score of new products being developed specifically for diseases of the developing world, creating new challenges for regulators in Africa and elsewhere. However, it is not at all certain that African regulatory authorities currently have the capacity …
COLORECTAL cancer is a leading cause of mortality in both developed and developing countries. Screening methods for colon cancer depend on detecting the precancerous changes. Generally, colonoscopy is carried out but the test is expensive (Rs 25,000-Rs 30,000) and the procedure highly invasive. An alternative is Fecal Occult Blood Test …
This is set to become a landmark case for the Indian pharmaceutical industry—and for patients. When Natco Pharma of Hyderabad wrote to Pfizer, the world’s largest drugs manufacturer, that it wanted a voluntary licence (VL) to make a low-cost version of its antiretroviral drug maraviroc, it was setting the stage …
Already banned in developed nations after it was found to be causing adverse health effects, the analgesic nimesulide may now be suspended from paediatric use in India too. The Drug Controller General of India (DCGI) Dr Surinder Singh will take a final call on the fate of the drug on …
First the good news: the year 2010 saw for the first time the Rs 52,271-crore Indian drug market throw up a Rs 200-crore plus brand. However, this comes with a bitter pill
The Institute of Microbial Technology (IMTECH), a part of the Council for Scientific and Industrial Research (CSIR), today got a bio-pharmaceutical laboratory, which is a one-of-its kind in the public sector. Union Science & Technology Minister Pawan Kumar Bansal inaugurated the facility at the IMTECH premises in Sector 39, Chandigarh. …
NATCO Pharma plans to seek a compulsory licence from the government to make Bayer AG's Nexavar in India, invoking a provision in local laws that allows generic drugmakers to make and sell patented drugs cheaply if the medicine is unaffordable. The development, a test case for such licensing in India, …
Nearly 2 billion people (a third of the world's population) lack access to essential medicines. In low-income and middle-income countries, drugs account for 20
The evolution of antibiotic resistance (AR) increases treatment cost and probability of failure, threatening human health worldwide. The relative importance of individual antibiotic use, environmental transmission and rates of introduction of resistant bacteria in explaining community AR patterns is poorly understood. Evaluating their relative importance requires studying a region where …
This study was aimed at finding out the occurrence of medication errors and the occurrence of risk factors for medication errors in the inpatient setting of the general hospitals in Delhi. 20 doctors, 30 nurses, 45 pharmacists, 500 patients charts were the population involved in the study. It was recorded …
The first part of a series of three features on antimicrobial resistance looks at the French campaign that has been held up as an example of how to change the way antibiotics are prescribed. But, as Gary Humphreys reports, 10 years after the campaign
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response to the Sixty-second World Health Assembly’s resolution on prevention and control of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. Resolution WHA62.15, adopted in 2009, calls …
The last 10 years were a crucial transition period for the Indian pharmaceutical industry. The next 10 years will be more crucial, predict industry experts. The period between 2000 and 2010 witnessed India
Indomethacin, Trimethoprim Get Approval GLENMARK Pharmaceuticals said it has received the US health regulator's approval to market three generic products in the American market. Glenmark Generics Inc, the US-based subsidiary of the company has received final approval from the US Food and Drug Administration (USFDA) for two products -- Indomethacin …
